Management of cardiovascular disease in renal transplant recipients.
about
Vascular calcification, bone and mineral metabolism after kidney transplantationDoes belatacept improve outcomes for kidney transplant recipients? A systematic reviewNonadherence Behaviors and Some Related Factors in Kidney Transplant Recipients.Primary care of the renal transplant patient.Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.Longitudinal analysis of physical activity, fluid intake, and graft function among kidney transplant recipientsPrevalence and determinants of physical activity and fluid intake in kidney transplant recipients.Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single center.Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study.Considerations for a Primary Care Physician Assistant in Treating Kidney Transplant Recipients.Self-care strategies and barriers among kidney transplant recipients: a qualitative studyImpact of renal transplantation on cardiac morphological and functional characteristics in children and adults.Ten years experience with belatacept-based immunosuppression after kidney transplantation.Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies.Hypertension in kidney transplant recipients.Belatacept utilization recommendations: an expert position.Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis.Factors associated with cardiovascular target organ damage in children after renal transplantation.Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants.Should belatacept be the centrepiece of renal transplantation?Research priority setting in organ transplantation: a systematic review.Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant.Incidence, risk factors, and outcomes of stroke post-transplantation in patients receiving a steroid sparing immunosuppression protocol.Validity of cardiovascular risk prediction models in kidney transplant recipients.Impact of sympathetic renal denervation: a randomized study in patients after renal transplantation (ISAR-denerve).
P2860
Q26771400-81FD8E36-F713-45F0-B9BD-63EB2715AF3DQ28084644-73E7D084-D3C3-4938-AC37-18528BCB4615Q33723131-5189E5F3-FB78-484F-8ADA-398125147470Q33898744-F51E6989-F55E-4209-85A1-AA5C46C878FAQ34077023-A4C0DCDC-6099-4CF0-8A11-D969E456F2D4Q34078914-3E4AE8D6-F6A0-40E4-8A4F-8EBCE5B24E3BQ34078925-2A39C093-C3EB-4EAA-9BD1-E7D46D766790Q36172191-203DC8F1-D6B4-455F-850B-82EDFA7329BBQ36243924-408F2B29-827F-4314-9D9D-408A2E0E69D0Q36368442-1B3CE8EE-94C6-4C30-B2E1-EBC181576EF6Q36520106-41D3CD01-6232-422B-8D46-D47CD1BF3C9AQ37399686-02FD141B-FA6D-4D56-8BA1-B3F5BCFE3423Q37604599-1BB0D707-9875-4868-9C36-F267FAF70E3CQ37768590-FDA86724-E40F-4670-A94D-A83C1E41D7BEQ37850471-E7B1AE10-87F2-4A51-8E0E-03399010F4ADQ38064538-3E1399BA-54BD-4134-87C0-97B8DA1CDF76Q38516516-EC5E3B41-EE84-4EFD-83D2-D0BC8C934441Q38626501-B87A2F13-7577-40C4-9ED1-0177B16D2973Q38790777-8B61112F-9A39-44E3-B73A-BA61956C10C6Q38862002-AEE9EACF-1F58-461C-B537-434548468DC6Q39102329-1F0E0A80-2EF3-4A1D-ADC2-E39DE18DC363Q43749603-6BCAA762-D397-4651-8DEA-ABC52B5E6CA2Q44478456-89541286-C8E8-4358-9FDC-C62FDB433B54Q53148108-AF3C575F-ECA4-4085-9F94-271676FD66ECQ53674432-239416EC-B65E-4C10-A2E3-E08DD9911104
P2860
Management of cardiovascular disease in renal transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of cardiovascular disease in renal transplant recipients.
@en
Management of cardiovascular disease in renal transplant recipients.
@nl
type
label
Management of cardiovascular disease in renal transplant recipients.
@en
Management of cardiovascular disease in renal transplant recipients.
@nl
prefLabel
Management of cardiovascular disease in renal transplant recipients.
@en
Management of cardiovascular disease in renal transplant recipients.
@nl
P356
P1476
Management of cardiovascular disease in renal transplant recipients.
@en
P2093
Anushree C Shirali
Margaret J Bia
P304
P356
10.2215/CJN.05081107
P577
2008-02-20T00:00:00Z